Five minutes with ... Jörg Thomaier, head of IP at Bayer

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Five minutes with ... Jörg Thomaier, head of IP at Bayer

Joerg Thomaier.jpg

Each week Managing IP speaks to a different IP lawyer about their life and career

Welcome to the latest instalment of Managing IP’s new series, ‘Five minutes with’, where we learn more about IP lawyers on a personal as well as a professional level. This time we have Jörg Thomaier, head of IP at Bayer.

Someone asks you at a party what you do for a living. What do you say?

That’s a difficult one – “Making sure that research is sustainable and worth the endeavour to fight hunger and diseases”. My son, when he was little and we drove to the Bayer facility during winter when a lot of steam was visible, said: “Daddy is making hot air”. It's kind of true when your tools are words …

Talk us through a typical working day.

Get up, screen through emails that arrived during the night, have first calls with Asia if needed, a couple of meetings on substance, litigation strategy, IP advocacy and the like. Do some paperwork - IP-related but also financial and HR matters. Keep up with incoming emails - delegate, delete, put on 'to-do list'. Try and sneak in a break for sports. Close the day with some interaction cross-Atlantic to cover time-zone gaps.

What are you working on at the moment?

Mainly IP litigation - defence and enforcement of our products, and strategy for the department.

Does one big piece of work usually take priority or are you juggling multiple things?

It's always a mixture of multiple things to juggle and the challenge is to prioritise them.

What is the most exciting aspect of your role and what is the most stressful?

I love working with people and developing talent. Making your numbers, especially in difficult times, is certainly the most stressful. Both of these aspects are not what you are trained for as an IP person. However, in a leadership role, it's what makes the difference between a leader and 'just' an expert - which we all are in our fields.

Tell us the key characteristics that make a successful IP lawyer.

Deep scientific and technological understanding. Strategic thinking and being business-minded. Knowing the law and the ability to communicate complex matters in a simple way to business partners, judges and juries.

What is the most common misconception about IP?

That it represents an obstacle to innovation. It is to the contrary, as IP is an important enabler of innovation. There won’t be innovation if people are not able to benefit from their ideas.

What or who inspires you?

Wow, that's difficult. Inspiration is a high threshold. I admire exceptional athletes and great thinkers in science. My wife and kids always are, and have been, a source of thinking, reflection and calibration.

If you weren’t an IP lawyer, what would you be doing?

I would be a scientist, like I was before I went into IP, either in STEM or a true nerd all day with a computer.

Any advice you would give your younger self?

Do it again this way but carve out more time for your kids when they are young.

more from across site and SHARED ros bottom lb

More from across our site

New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Gift this article